Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · IEX Real-Time Price · USD

6.03

-0.24 (-3.83%)

At close: Jul 2, 2024, 4:00 PM

6.00

-0.03 (-0.50%)

After-hours: Jul 2, 2024, 5:05 PM EDT

Fennec Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2002
Net Income	-16.05	-23.71	-17.35	-18.11	-12.78	Upgrade
Share-Based Compensation	5.35	4.22	4.02	2.88	3.08	Upgrade
Other Operating Activities	-6.45	1.44	-0.89	-0.36	0.63	Upgrade
Operating Cash Flow	-17.14	-18.06	-14.22	-15.6	-9.06	Upgrade
Share Issuance / Repurchase	0	0	0	31.97	0	Upgrade
Debt Issued / Paid	5	19.94	5	0	0	Upgrade
Other Financing Activities	1.64	0.8	-0.02	0.32	-0.07	Upgrade
Financing Cash Flow	6.64	20.73	4.98	32.29	-0.07	Upgrade
Net Cash Flow	-10.51	2.67	-9.24	16.69	-9.13	Upgrade
Free Cash Flow	-17.14	-18.06	-14.22	-15.6	-9.06	Upgrade
Free Cash Flow Margin	-80.67%	-1176.42%	-	-9173.53%	-	Upgrade
Free Cash Flow Per Share	-0.65	-0.69	-0.55	-0.66	-0.46	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).